Skip to main content

Johns Hopkins Receives $30M Gift to Build Center Housing Personalized Medicine Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Johns Hopkins University announced on Monday that its Whiting School of Engineering has received a $30 million gift, which it will use to build a facility to house personalized medicine initiatives by the school as well as other areas.

The gift is from John Malone, chairman of Liberty Media and an alumnus of Johns Hopkins. He received his master's degree in industrial management from the school in 1964, and a PhD in operations in 1967.

The $30 million will go toward construction of a 56,000-square-foot building on the university's Homewood campus, where it will be home to two planned interdisciplinary research efforts, including work into personalized medicine. Research at the building, to be called Malone Hall, will bring together engineers, life scientists, and medical researchers from across the university in an effort to integrate information science into the practice of medicine with an initial focus on cancer, the school said in a statement.

"The approach grows out of the recognition that genetic and epigenetic differences among patients explain, at least in part, why traditionally developed drugs help some people and not others," the school said.

Malone Hall also will be headquarters for the Systems Institute, which will use a multidisciplinary approach "to re-engineer entire systems of national importance, including medicine, healthcare delivery, network-enabled systems, information security, national infrastructure, and education," Johns Hopkins said.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.